Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hirsch-Ginsberg

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Hematologic Pathology|January 1, 1994
Characteristics and outcome of patients with acute lymphocytic leukemia and myeloperoxidase-positive blasts by electron microscopyA Preti, H M Kantarjian, E Estey, et al.
Stem Cells (Dayton, Ohio)|November 1, 1994
Interleukin 4 alters human bone marrow stroma and modulates its interaction with hematopoietic progenitorsA Ferrajoli, M Talpaz, N G Ordonez, et al.
Blood|July 1, 1992
Response assessment in chronic lymphocytic leukemia after fludarabine plus prednisone: clinical, pathologic, immunophenotypic, and molecular analysisL E Robertson, Y O Huh, J J Butler, et al.
American Journal of Clinical Pathology|December 1, 1990
Strategy for breakpoint cluster region analysis in chronic myelocytic leukemia in a routine clinical laboratoryL M Haber, C C Childs, C Hirsch-Ginsberg, et al.
British Journal of Haematology|July 1, 1991
Differential dose-related haematological effects of GM-CSF in pancytopenia: evidence supporting the advantage of low- over high-dose administration in selected patientsR Kurzrock, M Talpaz, J A Gomez, et al.
Journal of Cellular Physiology|March 1, 1996
Role of granulocyte-macrophage colony-stimulating factor in Philadelphia (Ph1)-positive acute lymphoblastic leukemia: studies on two newly established Ph1-positive acute lymphoblastic leukemia cell lines (Z-119 and Z-181)Z Estrov, M Talpaz, T F Zipf, et al.
Blood|September 15, 1990
RAS mutations are rare events in Philadelphia chromosome-negative/bcr gene rearrangement-negative chronic myelogenous leukemia, but are prevalent in chronic myelomonocytic leukemiaC Hirsch-Ginsberg, A C LeMaistre, H Kantarjian, et al.
Cancer|September 15, 1995
The breakpoint cluster region site in patients with Philadelphia chromosome-positive chronic myelogenous leukemia. Clinical, laboratory, and prognostic correlationsC F Verschraegen, H M Kantarjian, C Hirsch-Ginsberg, et al.
Blood|January 1, 1988
Phenotypic and molecular heterogeneity in Philadelphia chromosome-positive acute leukemiaC Hirsch-Ginsberg, C Childs, K S Chang, et al.
Hematologic Pathology|January 1, 1988
Heterogeneity in acute undifferentiated leukemiaA LeMaistre, C C Childs, C Hirsch-Ginsberg, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Hematologic Pathology|January 1, 1994
Characteristics and outcome of patients with acute lymphocytic leukemia and myeloperoxidase-positive blasts by electron microscopyA Preti, H M Kantarjian, E Estey, et al.
Stem Cells (Dayton, Ohio)|November 1, 1994
Interleukin 4 alters human bone marrow stroma and modulates its interaction with hematopoietic progenitorsA Ferrajoli, M Talpaz, N G Ordonez, et al.
Blood|July 1, 1992
Response assessment in chronic lymphocytic leukemia after fludarabine plus prednisone: clinical, pathologic, immunophenotypic, and molecular analysisL E Robertson, Y O Huh, J J Butler, et al.
American Journal of Clinical Pathology|December 1, 1990
Strategy for breakpoint cluster region analysis in chronic myelocytic leukemia in a routine clinical laboratoryL M Haber, C C Childs, C Hirsch-Ginsberg, et al.
British Journal of Haematology|July 1, 1991
Differential dose-related haematological effects of GM-CSF in pancytopenia: evidence supporting the advantage of low- over high-dose administration in selected patientsR Kurzrock, M Talpaz, J A Gomez, et al.
Journal of Cellular Physiology|March 1, 1996
Role of granulocyte-macrophage colony-stimulating factor in Philadelphia (Ph1)-positive acute lymphoblastic leukemia: studies on two newly established Ph1-positive acute lymphoblastic leukemia cell lines (Z-119 and Z-181)Z Estrov, M Talpaz, T F Zipf, et al.
Blood|September 15, 1990
RAS mutations are rare events in Philadelphia chromosome-negative/bcr gene rearrangement-negative chronic myelogenous leukemia, but are prevalent in chronic myelomonocytic leukemiaC Hirsch-Ginsberg, A C LeMaistre, H Kantarjian, et al.
Cancer|September 15, 1995
The breakpoint cluster region site in patients with Philadelphia chromosome-positive chronic myelogenous leukemia. Clinical, laboratory, and prognostic correlationsC F Verschraegen, H M Kantarjian, C Hirsch-Ginsberg, et al.
Blood|January 1, 1988
Phenotypic and molecular heterogeneity in Philadelphia chromosome-positive acute leukemiaC Hirsch-Ginsberg, C Childs, K S Chang, et al.
Hematologic Pathology|January 1, 1988
Heterogeneity in acute undifferentiated leukemiaA LeMaistre, C C Childs, C Hirsch-Ginsberg, et al.
Pageof 3